- OBD's PSE test to be used in NCI trial
- OBD develops multi-cancer diagnostic test for dogs
- Notice of Results
- OBD partners with Goodbody Clinic on PSE test
- OBD partners with The London Clinic for PSE & CiRT
- OBD and King's College London collaborate on RA
- Holding(s) in Company
- Results of GM
- OBD opens UK clinical testing facility
- Result of AGM
More ▼
Key statistics
On Friday, Oxford Biodynamics PLC (OBD:LSE) closed at 7.36, 3.37% above its 52-week low of 7.12, set on Jun 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.32 |
---|---|
High | 7.40 |
Low | 7.32 |
Bid | 7.10 |
Offer | 8.00 |
Previous close | 7.44 |
Average volume | 745.26k |
---|---|
Shares outstanding | 311.86m |
Free float | 263.69m |
P/E (TTM) | -- |
Market cap | 22.95m GBP |
EPS (TTM) | -0.0729 GBP |
Data delayed at least 20 minutes, as of Jun 14 2024 16:03 BST.
More ▼